FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review - Nasdaq

FDA Accepts Sanofi's BLA for Meningitis Vaccine to Review  Nasdaq

Sanofi SNY announced that the FDA has accepted for review its biologics license application (BLA) for MenQuadfi, a meningococcal vaccine.



Comments

Popular posts from this blog